Abstract:Acute ischemic stroke is a major factor cause of severe morbidity and mortality in general population. Newer modality of treatment like IV thrombolysis has been established to prevent long term complications in this condition within 4.5 hours of symptoms onset. The data regarding IV thrombolysis is limited in rural areas. Various factors like lack of awareness among general population, patients reaching hospital beyond window period, cost of treatment pose difficulty in administration of this treatment. This article presents demographic profile of patients undergoing IV thrombolysis for acute ischemic stroke at a hospital from Kutch, Gujarat. This article also highlights the importance of strong interpersonal communication between physician for better outcomes in patients. The aim of this observational study is to observe demographic profile of patients with acute ischemic stroke receiving intravenous thrombolysis and to estimate the factors which might help in favorable patient outcome. The data was calculated during January 2023 to December 2023. 22 patients were thrombolysed for acute ischemic stroke within 4.5 hours from onset of symptoms. Males were predominant (86.3%), average age of patients was 57.4 years (range 31 – 80 years old). Majority of the strokes were anterior circulation stroke (77.2%). The comorbidities like Diabetes mellitus (36.3%), hypertension (54.5%), dyslipidemia (59%), old coronary artery disease (18%), old cerebro vascular disease (4.5%) were seen. The time from symptom onset to presentation to hospital is approximately 146 minutes. The time from presentation to hospital and IV thrombolysis administration is approximately 49 minutes. 17(77.2%) patients presented to hospital within 3 hours of symptom onset, 13 (59%) underwent IV thrombolysis within 30 minutes of presentation to hospital. Majority of this patients were referred by primary physician to the hospital. Mild stroke (NIHSS < 5) was seen in 1 (4.5%) patient, moderate (NIHSS 5-15) in 11(50%) patients, moderate -severe stroke (NIHSS 15-25)– in 10(45.5%) patients. Large vessel occlusion was seen in 12 (54.5 %), small vessel disease in 4 (18 %), Embolic etiology in 4(18%) and unknown in 2 (9%) of cases. The mean NIHSS at presentation was approximately 16, at 24 hours after IV thrombolysis was approximately 11.3 and after 72 hours of IV thrombolysis is 8.6. Early neurological deficit was seen in 6(27.2%) of cases. 4(18%) of all stroke who underwent thrombolysis required decompression craniotomy. The improving on mRS (grade 0-1) score was found in 16(72.8%) patients at 7 days of thrombolysis. Intravenous thrombolysis with recombinant tissue plasminogen activator is helpful in acute ischemic stroke within 4.5 hours of onset. Early diagnosis and swift evaluation and management helps in prevention of longterm disability.

STUDY OF INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE IN THE SOUTHERN PART OF INDIAAND ITS OUTCOME, A SINGLE CENTER STUDY

Experience of tenecteplase in acute ischemic stroke from Kutch, Gujarat; Strong interpersonal communication between doctors leads to favorable outcomes

Abstract 26: Regional Inequities in Access to Stroke Facilities in India - Estimating Travel Distance and Times for Thrombolysis and Thrombectomy

Intravenous thrombolysis in acute ischemic stroke: A prospective cross-sectional observational study in Kashmir

Intravenous Thrombolytic Therapy among 25 Patients with Acute Ischemic Stroke

Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes

Acute Stroke in the Emergency Department: Profiles of Patients and Obstacles to Acute Intervention

Effectiveness and prognosis-related factors of intravenous thrombolysis in patients with acute ischemic stroke

Outcome of intravenous thrombolysis in acute ischemic stroke patients with small vessel disease

Factors affecting improvement after intravenous administration of recombinant tissue plasminogen activator (rtPA) among patients with acute ischemic stroke: A historical cohort study

Expansion of the dimensions in the current management of acute ischemic stroke

Advanced Age and Higher National Institutes of Health Stroke Scale Score as Predictors of Poor Outcome in Ischemic Stroke Patients Treated with Alteplase: A Study from a Tertiary Care Centre in Rural North-west India

Endovascular Administration after Intravenous Infusion of Thrombolytic Agents for the Treatment of Patients with Acute Ischemic Strokes

DOOR-TO-NEEDLE TIME AND THE FACTORS IMPEDING THROMBOLYSIS OF ACUTE STROKE PATIENTS AT A TERTIARY CARE CENTER IN INDIA

Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1

Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants - A Growing Dilemma Also in India

Abstract TP102: Pre-Hospital Obtention of Vital Information for Decision Enforcement in Cerebrovascular Emergencies: The PROVIDENCE Study

RE-OPEN: Randomised trial of biosimilar TNK versus TPA during endovascular therapy for acute ischaemic stroke due to large vessel occlusions

[Emergency endovascular management of ischemic stroke. Experience in 104 patients]

Abstract TP75: Safety and Outcome of Thrombolysis in Acute Stroke with Prolonged Onset-to-Treatment Times and Low National Institute of Health Stroke Scale Scores. Report on Experience in China, First 1000 Patients of 3300 Treated

The Clinical Study of Thrombolysis with rt-PA in Acute Ischemic Stroke